Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

한국어

Shaperon Inc.

샤페론378800KOSDAQSector: Pharma & Biotech
₩5070.20%Market cap ₩23.4BAs of Aug 31, 2026 close · updated once daily
Market cap
₩23.4B
#1551 in KOSDAQ
Loss
PER not computable
0.95x
Sector median 1.59x
0.0%
Sector median 0.0%
D
Grade D48.4 ptsBottom 45% of 2,523 graded stocksPreviously CMethodology v2.0

As of Aug 31, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCDCurrentF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band D with a total score of 48.4 points.

Grade capped based on disclosed facts: designated as administrative issue

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩409High ₩2,955
Latest close
Price change by period
1W
9.20%
1M
21.00%
3M
58.50%
1Y
73.60%

Adjusted for 1 price-basis change(s) such as stock splits or reverse splits during the period.

As of the Aug 31, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

47.4/100
How much debt does it carry relative to equity?
12.7%
Sector median 51.6%
Sector lowhighTop 14.4% in sector
Can it cover what's due within a year?
1253.4%
Sector median 191.7%
Sector lowhighTop 11.9% in sector
How much of revenue becomes profit?
-6952.9%
Sector median -2.4%
Sector lowhighBottom 2.7% in sector
How much did it earn on its own capital?
-62.8%
Sector median -4.5%
Sector lowhighBottom 13.2% in sector

Source filing: annual report (consolidated) — view original

2

Growth momentum

70.7/100
How much did revenue grow in a year?
1186.7%
Sector median 6.4%
Sector lowhighTop 1.1% in sector
Did core profits grow in a year?
-4.6%
Sector median 3.6%
Sector lowhighBottom 42.4% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original

3

Price attractiveness

35.3/100
Is the price expensive relative to earnings?
Loss-making (P/E not computable)
Sector median P/E of profitable peers 16.1x · 58% loss-making
Sector lowhighBottom 5.1% in sector
Is the price expensive relative to book value?
0.95x
Sector median 1.59x
Sector lowhighTop 34.6% in sector

Valuation uses the Aug 31, 2026 close and market cap

4

Shareholder Return

Single-indicator axis37.5/100
Does the company actually pay dividends?
0.0%
Sector median 0.0%
Sector lowhighBottom 37.5% in sector

Source filing: annual report (consolidated) — view original

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 1, 2026

Of 9 items: 5 met · 4 not met · 0 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Not met
-₩15.5B
Positive operating cash flow
Whether cash flow from operations is above zero.
Not met
-₩14.5B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Not met
-59.6% → -80.5%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
-₩14.5B vs -₩15.5B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Met
17.0% → 11.2%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Met
754.2% → 1253.4%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Not met
30,143,031 → 46,243,031
Operating margin up
Whether operating income over revenue rose from the prior year.
Met
-85523.5% → -6952.9%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Met
0.00x → 0.01x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original

Grade change history

Aug 13, 2026CD

Grade cap applied per disclosed facts

Grade capped based on disclosed facts: designated as administrative issue

Jul 23, 2026C

Methodology version change (v2.0 applied)

Jul 15, 2026BCVersion v1.1

Methodology version change (v1.1 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Financial fact combinations

Operating losses for 3 consecutive fiscal years

Recorded operating losses in three consecutive fiscal years, FY2023–FY2025 (per annual reports).

Determined as of 2026-09-01

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 12, 2026Source
Periodic report filedMay 15, 2026Source

View in the filings calendar →